Barclays lifts Mosaic stock rating, raises target to $33

On Wednesday, Barclays (LON:BARC) analyst Benjamin Theurer upgraded shares of Mosaic (NYSE:MOS), a global leader in phosphate and potash crop nutrition, from Equalweight to Overweight and increased the price target from $27.00 to $33.00. The upgrade comes as the stock shows strong momentum, having gained over 10% in the past week and nearly 12% year-to-date. Theurer’s upgrade is based on the expectation that Mosaic will start seeing profit benefits this year following a period of significant project investments and macroeconomic challenges in 2024. According to InvestingPro data, analysts expect net income growth this year, with earnings per share projected at $2.23 for FY2025.

Theurer noted that Mosaic’s strategic reduction in facility maintenance, alongside investments aimed at lowering costs, is anticipated to bolster margins and diminish volatility. This focus on margin improvement is crucial, as InvestingPro data shows current gross profit margins at 13.59%. The company’s focus on growth regions like China and on expanding its product portfolio with items such as biologicals is expected to further enhance its profit base. Notably, Mosaic has maintained dividend payments for 15 consecutive years, currently offering a 3.24% yield.

While acknowledging that the updated estimates are below Mosaic’s own targets, Theurer clarified that this discrepancy is not due to a lack of confidence in the company. Instead, it is attributed to the ongoing uncertainty stemming from trade wars and geopolitical tensions. He emphasized that even if these macro headwinds prevent Mosaic from fully achieving its objectives, there is still considerable upside potential, as reflected in the new $33 price target.

Theurer also pointed out that an improvement in the trade environment could propel Mosaic’s stock even higher, as indicated by Barclays’ $38 upside case scenario. This potential rise would be contingent on the alleviation of trade-related headwinds, which would likely provide a substantial boost to the company’s stock performance.

In other recent news, Mosaic Company has been the focus of several analyst updates. BMO Capital Markets maintained an Outperform rating on Mosaic stock with a $44.00 price target, citing positive market conditions in potash and phosphate and a promising outlook for their Fertilizantes segment. However, Mosaic’s recent fourth-quarter earnings report showed a 37% decline in adjusted earnings per share, falling short of market expectations. Mizuho (NYSE:MFG) Securities responded to these results by lowering its price target from $29.00 to $28.00, maintaining a neutral stance due to concerns about the company’s earnings growth and market conditions.

Goldman Sachs initiated coverage on Mosaic with a Buy rating and a $31.00 price target, highlighting the potential for earnings and margin expansion as the company stabilizes its production. Barclays upgraded Mosaic’s rating from Underweight to Equalweight, setting a price target of $27.00, reflecting a more balanced risk-reward scenario for investors. Meanwhile, Scotiabank (TSX:BNS) adjusted its price target to $31.00 from $34.00, maintaining a Sector Outperform rating but noting the need for improvements in Mosaic’s portfolio performance and free cash flow conversion.

These developments reflect a varied outlook from analysts, with some expressing optimism about market conditions and others emphasizing the need for operational improvements. Investors are particularly focused on Mosaic’s upcoming Capital Markets Day, which may provide further insights into the company’s strategies for enhancing shareholder value.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.